Navigating Myeloma Therapy Choices in the Rapidly Changing Treatment Landscape
Gain a better understanding of newly approved multiple myeloma treatment agents, the options and benefits of participating in clinical trials, and new strategies that may be available for prolonging a patient’s response to treatment. Each webinar features a panel of leading experts who discuss each of the myeloma therapy choices.
|Newly Approved Drugs||Craig Emmitt Cole, MD
Kenlyn Laureys, DNP, FNP-C
|Clinical Trials||Joseph Mikhael, MD, MEd, FRCPC, FACP
Angela A. Mayo, PA-C, MS
This webinar will also feature a patient presenter, who will share personal stories of clinical trial participation.
|Prolonging the Treatment Response||Amrita Y. Krishnan, MD
Beth A. Landa, PA-C